FBFatma Budak

Fatma Budak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatma Budak has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecularly imprinted polymer-based electrochemical sensors for the analysis of antiviral drugs used in SARS-CoV-2: Innovations and recent applications

    by Fatma Budak, Ensar Piskin, Ahmet Cetinkaya, Sibel A. Özkan

    Viruses that cause infectious diseases pose a vital threat to the health of living beings. Antiviral drugs are widely used to treat these diseases. In recent years, due to the prevalence of infectious diseases and global epidemics, the use of antiviral medications has become increasingly widespread. In recent years, antiviral drugs, particularly SARS-CoV-2, have been used in the treatment of COVID-19, an infectious disease that has caused significant deaths worldwide. These drugs are primarily used to reduce the effects of viruses, prevent their spread, and treat the disease. Therefore, MIP-based electrochemical sensors are widely used to provide rapid, sensitive, reliable, stable, and, most importantly, selective detection of antiviral drugs. Furthermore, MIPs can be integrated into miniature devices, are reusable, and possess a highly stable structure even under harsh conditions. A review of the literature reveals that these significant advantages of MIP-based electrochemical sensors have made them a substantial asset in the selective and sensitive determination of antiviral drugs. This study investigates the applications, sensor designs, and properties of MIP-based electrochemical sensors, specifically designed for the drugs favipiravir, lopinavir, remdesivir, ribavirin, and umifenovir, which have been widely used in the treatment of SARS-CoV-2 infections in recent years, in both pharmaceutical and biological samples. Furthermore, this review will shed light on the analysis of these drugs and the methods to be developed in the coming years.

  • Open Access

    Applications of antiviral drugs with electrochemical sensors

    by Fatma Budak, Ensar Piskin, Ahmet Cetinkaya, Sibel A. Ozkan


  • Current Analytical Methods for the Sensitive Assay of New-Generation Ovarian Cancer Drugs in Pharmaceutical and Biological Samples

    by Ahmet Cetinkaya, S. Irem Kaya, Fatma Budak, Sibel A Ozkan

    Ovarian cancer, which affects the female reproductive organs, is one of the most common types of cancer. Since this type of cancer has a high mortality rate from gynaecological cancers, the scientific community shows great interest in studies on its treatment. Chemotherapy, radiotherapy, and surgical treatment methods are used in its treatment. In the absence of targeted treatments in these treatment methods, side effects occur in patients, and patients show resistance to the drug. In addition, the underlying causes of ovarian cancer are still not fully known. The scientific world thinks that genetic factors, environmental conditions, and consumed foods may cause this cancer. The most important factor in the treatment of ovarian cancer is early diagnosis. Therefore, the drugs used in the treatment of ovarian cancer are platinum-based anticancer drugs. In addition to these drugs, the most preferred treatment method recently is targeted treatment approaches using poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors. In this review, studies on the sensitive analysis of the treatment methods of these new-generation drugs used in the treatment of ovarian cancer have been comprehensively examined. In addition, the basic features, structural aspects, and biological data of analytical methods used in treatments with new-generation drugs are explained. Analytical studies carried out in the literature in recent years aim to show future developments in how these new-generation drugs are used today and to guide future studies by comprehensively examining and explaining the structure-activity relationship, mechanism of action, toxicity, and pharmacokinetic studies. Finally, in this study, the methods used in the analysis of drugs used in the treatment of ovarian cancer and the studies conducted between 2015 and 2023 were discussed in detail.


  • Carbon Nanomaterials-Based Novel Hybrid Platforms for Electrochemical Sensor Applications in Drug Analysis

    by Ahmet Cetinkaya, S. Irem Kaya, Goksu Ozcelikay, Fatma Budak, Sibel A. Ozkan

    Nowadays, the rapid improvements in the medical and pharmaceutical fields increase the diversity and use of drugs. However, problems such as the use of multiple or combined drugs in the treatment of diseases and insensible use of over-the-counter drugs have caused concerns about the side-effect profiles and therapeutic ranges of drugs and environmental contamination and pollution problems due to pharmaceuticals waste. Therefore, the analysis of drugs in various media such as biological, pharmaceutical, and environmental samples is an important topic of discussion. Electrochemical methods are advantageous for sensor applications due to their easy application, low cost, versatility, high sensitivity, and environmentally-friendliness. Carbon nanomaterials such as diamond-like carbon thin films, carbon nanotubes, carbon nanofibers, graphene oxide, and nanodiamonds are used to enhance the performance of the electrochemical sensors with catalytic effects. To further improve this effect, it is aimed to create hybrid platforms by using different carbon nanomaterials together or with materials such as conductive polymers and ionic liquids. In this review, the most used carbon nanoforms will be evaluated in terms of electrochemical characterizations and physicochemical properties. Furthermore, the effect of hybrid platforms developed in the most recent studies on electrochemical sensors will be examined and evaluated in terms of drug analysis studies in the last five years.